Skip to content
NBDC Human Database

No datasets in the cart.

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

NHA000186

Type of data
GWAS for bullous pemphigoid
Access criteria
Unrestricted-access
Total data volume
43.0 MB
File formats
  • XLSX
  • ZIP
Research
hum0163
Date published
2023-04-21
Date modified
2023-04-21
Secondary ID
hum0163.v3.BPgwas.v1

Unrestricted-access files linked to this dataset

FileLabelSizeCopy URL
hum0163.v3.BPgwas.v1.zip43.0 MB
hum0163.v3_gwas_header.xlsxDictionary file9.8 KB

Analysis method

Genotyping by array

Materials and participants
bullous pemphigoid (ICD10: L12.0): 90 cases
737 healthy controls
  • Health status
    Mixed
  • Subject count
    827 (Mixed)
  • Population
    Japanese
Disease
bullous pemphigoid (L120)
Sample description
DNA extracted from peripheral blood cells of bullous pemphigoid patients and B-lymphoblast cell lines
  • Tissue
    B cell line, Peripheral blood
  • Tumor / normal
    Normal
Cell line
Japanese B cell line
Sample provider
737 general populations derived from Epstein-Barr virus-transformed B-lymphoblast cell lines of unrelated Japanese individuals established by the Pharma SNP Consortium (PSC)
Experimental method
Genotyping by array
Target
N/A
Reagent kit
HumanOmniExpressExome BeadChip Kit
Platform
Illumina HumanOmniExpressExome
Reference genome
GRCh37
QC and filtering
sample call rate < 0.99, SNP call rate < 0.99, HWE-P < 1x10^-6
Analysis method
GenCall software (GenomeStudio)
Variant count
526,267 SNPs (Autosomes)